期刊文献+

左旋甲状腺素与三碘甲状腺原氨酸能否联合治疗?

Can the Combined Therapy of L-T4 and T3 be Used in Hypothyrodism?
下载PDF
导出
摘要 甲减是目前常见的内分泌疾病,目前主要的治疗方法是甲状腺激素替代治疗。但是部分患者甲状腺激素替代治疗后效果不佳,有学者进行了L-T4与T3联合治疗甲减,发现联合治疗后效果显著,需要进一步明确联合治疗的可行性及必要性。 Hypothyoidism is a common endocrine disease, and the therapy of thyroid hormone replacement is the main treatment. But there is no good effect in some patients with hypothyroidism after thyroid hormone replacement therapy. Therefore, some scholars conducted a combined therapy of L-T4 and T3 for these patients, and found that the combined therapy was effective. Consequently, we need to further confirm the feasibility and necessity of combination therapy.
出处 《药品评价》 CAS 2016年第5期5-7,36,共4页 Drug Evaluation
关键词 甲状腺功能减退 左旋甲状腺素钠 三碘甲状腺原氨酸 联合治疗 Hypothyoidism L-T4 T3 Combined Therapy
  • 相关文献

参考文献26

  • 1Cooper DS, Biondi B 2012 Subclinical thyroid disease. Lancet 379:1142- 1154.
  • 2Hoang TD, Olsen CH, Mai VQ, et al. desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: arandomized, double-blind, crossover study[J]. J Clin Endocrinol Metub, 2013, 98(5): 1982-1990.
  • 3Wartofsky L. Combination L-T3 and L-T4 therapy for hypothyroidism[J]. Curr Opin Endocrinol Diabetes Obes, 2013, 20(5): 460-466.
  • 4Zhu DF, Wang ZX, Zhang DR, et al. f MRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism[J]. Brain, 2006, 129: 2923-2930.
  • 5Bauer M, Silverman DH, Schlagenhauf F, et al. Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy[J]. J Clin Endocrinol Metab, 2009, 94: 2922-2929.
  • 6Cooper DS. thyroxine monotherapy after thyroidectomy: coming full circle[J]. JAMA, 2008, 299(7): 817-819.
  • 7Biondi B, Wartofsky I. Combination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism[J]. J Clin Endoerinol Metab, 2012, 97(7): 2256-2271.
  • 8Canaris G J, Manowitz NR, Mayor G, et aL The Colorado thyroid disease prevalence study[J]. Arch Intern Med, 2000, 160(4): 526-534.
  • 9Abdalla SM, Bianco AC. Defending plasma T3 is a boilogical priority[J]. J Clin Endocrinol(Oxf), 2014, 81(5): 633-641.
  • 10Walsh JP, Ward LC, Burke V, et al. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: result of a double-blind, randomized clinical trial[J]. J Clin Endocrinol Metab, 2006, 91 (7): 2624-2230.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部